New leaders named to Vanderbilt-Ingram research programs
Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.
Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.
A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population. The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by VUMC, is a multisite research study conducting long-term follow-up on men who were diagnosed with localized prostate cancer between 2011 and 2012.
Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.
A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.